Bill Text: TX SB27 | 2013 | 83rd Legislature 1st Special Session | Introduced


Bill Title: Relating to the designation for criminal prosecution and other purposes of certain chemicals commonly referred to as synthetic cannabinoids as controlled substances and controlled substance analogues under the Texas Controlled Substances Act.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2013-06-06 - Filed [SB27 Detail]

Download: Texas-2013-SB27-Introduced.html
  83S10306 JSC-D
 
  By: Huffman S.B. No. 27
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the designation for criminal prosecution and other
  purposes of certain chemicals commonly referred to as synthetic
  cannabinoids as controlled substances and controlled substance
  analogues under the Texas Controlled Substances Act.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subdivisions (5) and (6), Section 481.002,
  Health and Safety Code, are amended to read as follows:
               (5)  "Controlled substance" means a substance,
  including a drug, an adulterant, and a dilutant, listed in
  Schedules I through V or Penalty Group [Groups] 1, 1-A, [or] 2, 2-A,
  3, or [through] 4. The term includes the aggregate weight of any
  mixture, solution, or other substance containing a controlled
  substance.
               (6)  "Controlled substance analogue" means:
                     (A)  a substance with a chemical structure
  substantially similar to the chemical structure of a controlled
  substance in Schedule I or II or Penalty Group 1, 1-A, [or] 2, or
  2-A; or
                     (B)  a substance specifically designed to produce
  an effect substantially similar to, or greater than, the effect of a
  controlled substance in Schedule I or II or Penalty Group 1, 1-A,
  [or] 2, or 2-A.
         SECTION 2.  Section 481.1031, Health and Safety Code, is
  amended to read as follows:
         Sec. 481.1031.  PENALTY GROUP 2-A.  Penalty Group 2-A
  consists of any material, compound, mixture, or preparation that
  contains any quantity of a synthetic chemical substance, including
  its salts, isomers, and salts of isomers, listed by name in this
  section or contained within the following structural classes
  defined in this section [compound that is a cannabinoid receptor
  agonist and mimics the pharmacological effect of naturally
  occurring cannabinoids, including]:
                     WIN-55,212-2;
               Naphthoylindole: any compound [naphthoylindoles]
  structurally derived from 3-(1-naphthoyl)indole or
  3-(2-naphthoyl)indole by substitution at the nitrogen atom of the
  indole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
  haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
  cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
  (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl
  [2-(4-morpholinyl)ethyl], whether or not further substituted in
  the indole ring to any extent, whether or not substituted in the
  naphthyl [napthyl] ring to any extent, including:
                     AM-1220;
                     AM-2201;
                     JWH-004;
                     JWH-007;
                     JWH-009;
                     JWH-015;
                     JWH-016;
                     JWH-018;
                     JWH-019;
                     JWH-020;
                     JWH-046;
                     JWH-047;
                     JWH-048;
                     JWH-049;
                     JWH-050;
                     JWH-073;
                     JWH-076;
                     JWH-079;
                     JWH-080;
                     JWH-081;
                     JWH-082;
                     JWH-083;
                     JWH-093;
                     JWH-094;
                     JWH-095;
                     JWH-096;
                     JWH-097;
                     JWH-098;
                     JWH-099;
                     JWH-100;
                     JWH-116;
                     JWH-122;
                     JWH-148;
                     JWH-149;
                     JWH-153;
                     JWH-159;
                     JWH-164;
                     JWH-165;
                     JWH-166;
                     JWH-180;
                     JWH-181;
                     JWH-182;
                     JWH-189;
                     JWH-193;
                     JWH-198;
                     JWH-200;
                     JWH-210;
                     JWH-211;
                     JWH-212;
                     JWH-213;
                     JWH-234;
                     JWH-235;
                     JWH-239;
                     JWH-240;
                     JWH-241;
                     JWH-242;
                     JWH-258;
                     JWH-259;
                     JWH-260;
                     JWH-262;
                     JWH-267;
                     JWH-386;
                     JWH-387;
                     JWH-394;
                     JWH-395;
                     JWH-397;
                     JWH-398;
                     JWH-399;
                     JWH-400;
                     JWH-412;
                     JWH-413; and
                     JWH-414;
               Naphthylmethylindole: any compound
  [naphthylmethylindones] structurally derived from
  1H-indol-3-yl-(1-naphthyl)methane or
  1H-indol-3-yl-(2-naphthyl)methane by substitution at the nitrogen
  atom of the indole ring by alkyl, haloalkyl, benzyl, halobenzyl,
  alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl,
  cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
  (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl
  [2-(4-morpholinyl)ethyl], whether or not further substituted in
  the indole ring to any extent, whether or not substituted in the
  naphthyl ring to any extent, including:
                     JWH-175;
                     JWH-184;
                     JWH-185;
                     JWH-192;
                     JWH-194;
                     JWH-195;
                     JWH-196;
                     JWH-197; and
                     JWH-199;
               Naphthylindolecarboxamide: any compound structurally
  derived from N-(naphthalen-1-yl)-1H-indole-3-carboxamide or
  N-(naphthalen-2-yl)-1H-indole-3-carboxamide by substitution at
  the nitrogen atom of the indole ring by alkyl, haloalkyl, benzyl,
  halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
  hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
  (N-methylpiperidin-2-yl)alkyl or 2-(4-morpholinyl)alkyl, whether
  or not further substituted in the indole ring to any extent, whether
  or not substituted in the naphthyl ring to any extent, including:
                     MN-24 (Other name: NNEI);
               Naphthoylpyrrole: any compound [naphthoylpyrroles]
  structurally derived from 3-(1-naphthoyl)pyrrole or
  3-(2-naphthoyl)pyrrole by substitution at the nitrogen atom of the
  pyrrole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
  haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
  cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
  (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl
  [2-(4-morpholinyl)ethyl], whether or not further substituted in
  the pyrrole ring to any extent, whether or not substituted in the
  naphthyl ring to any extent, including:
                     JWH-030;
                     JWH-145;
                     JWH-146;
                     JWH-147;
                     JWH-150;
                     JWH-156;
                     JWH-243;
                     JWH-244;
                     JWH-245;
                     JWH-246;
                     JWH-292;
                     JWH-293;
                     JWH-307;
                     JWH-308;
                     JWH-309;
                     JWH-346;
                     JWH-347;
                     JWH-348;
                     JWH-363;
                     JWH-364;
                     JWH-365;
                     JWH-366;
                     JWH-367;
                     JWH-368;
                     JWH-369;
                     JWH-370;
                     JWH-371;
                     JWH-372;
                     JWH-373; and
                     JWH-392;
               Naphthylmethylindene: any compound
  [naphthylmethylindenes] structurally derived from
  1-(1-naphthylmethyl)indene or 1-(2-naphthylmethyl)indene by
  substitution at the 3-position of the indene ring by alkyl,
  haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
  cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
  (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
  2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl], whether or not
  further substituted in the indene ring to any extent, whether or not
  substituted in the naphthyl ring to any extent, including:
                     JWH-171;
                     JWH-172;
                     JWH-173; and
                     JWH-176;
               Phenylacetylindole: any compound [phenylacetylindoles]
  structurally derived from 3-phenylacetylindole by substitution at
  the nitrogen atom of the indole ring with alkyl, haloalkyl, benzyl,
  halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
  hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
  (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
  2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl], whether or not
  further substituted in the indole ring to any extent, whether or not
  substituted in the phenyl ring to any extent, including:
                     [AM-694;
                     [AM-1241;]
                     JWH-167;
                     JWH-203;
                     JWH-204;
                     JWH-205;
                     JWH-206;
                     JWH-208;
                     JWH-237;
                     JWH-248;
                     JWH-249;
                     JWH-250;
                     JWH-251;
                     JWH-252;
                     JWH-253;
                     JWH-302;
                     JWH-303;
                     JWH-305;
                     JWH-306;
                     JWH-311;
                     JWH-312;
                     JWH-313;
                     JWH-314; [and]
                     JWH-315; and
                     RCS-8;
               Benzoylindole: any compound structurally derived from
  3-benzoylindole by substitution at the nitrogen atom of the indole
  ring with alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
  haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
  cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
  (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or
  not further substituted in the indole ring to any extent, whether or
  not substituted in the phenyl ring to any extent, including:
                     AM-630;
                     AM-679;
                     AM-694;
                     AM-1241;
                     Pravadoline (Other name: WIN 48,098); and
                     RCS-4;
               Adamantoylindole: any compound structurally derived
  from 3-(1-adamantoyl)indole or 3-(2-adamantoyl)indole by
  substitution at the nitrogen atom of the indole ring with alkyl,
  haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
  cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
  (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
  2-(4-morpholinyl)alkyl, whether or not further substituted in the
  indole ring to any extent, whether or not substituted in the
  adamantyl ring to any extent, including:
                     AB-001; and
                     AM-1248;
               Adamantylindolecarboxamide: any compound structurally
  derived from N-(adamantan-1-yl)-1H-indole-3-carboxamide or
  N-(adamantan-2-yl)-1H-indole-3-carboxamide by substitution at the
  nitrogen atom of the indole ring by alkyl, haloalkyl, benzyl,
  halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
  hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
  (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
  2-(4-morpholinyl)alkyl, whether or not further substituted in the
  indole ring to any extent, whether or not substituted in the
  adamantyl ring to any extent, including:
                     APICA; and
                     STS-135;
               Adamantylindazolecarboxamide: any compound
  structurally derived from
  N-(adamantan-1-yl)-1H-indazole-3-carboxamide or
  N-(adamantan-2-yl)-1H-indazole-3-carboxamide by substitution at
  the 1-position nitrogen atom of the indazole ring by alkyl,
  haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
  cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
  (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
  2-(4-morpholinyl)alkyl, whether or not further substituted in the
  indazole ring to any extent, whether or not substituted in the
  adamantyl ring to any extent, including:
                     5-Fluoro AKB-48; and
                     AKB-48;
               Aminooxobutylindazolecarboxamide: any compound
  structurally derived from
  N-(1-amino-3-methyl-1-oxobutan-2-yl)-1H-indazole-3-carboxamide
  by substitution at the 1-position nitrogen atom of the indazole
  ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl,
  haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl,
  cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl,
  (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or
  not further substituted in the indazole ring to any extent,
  including:
                     AB-PINACA; and
                     AB-FUBINACA;
               Tetramethylcyclopropylindole: any compound
  structurally derived from
  3-(2,2,3,3-tetramethylcyclopropylcarbonyl)indole by substitution
  at the nitrogen atom of the indole ring by alkyl, haloalkyl, benzyl,
  halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
  hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
  (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
  2-(4-morpholinyl)alkyl, whether or not further substituted in the
  indole ring to any extent, whether or not substituted in the
  tetramethylcyclopropyl ring to any extent, including:
                     A-834,735;
                     A-796,260;
                     AB-005;
                     UR-144;
                     5-Bromo UR-144;
                     5-Chloro UR-144; and
                     5-Fluoro UR-144 (Other name: XLR-11);
               Tetramethylcyclopropane-thiazole carboxamide: any
  compound structurally derived from
  2,2,3,3-tetramethyl-N-(thiazol-2-ylidene)cyclopropanecarboxamide
  by substitution at the nitrogen atom of the thiazole ring by alkyl,
  haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
  cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
  (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
  2-(4-morpholinyl)alkyl, whether or not further substituted in the
  thiazole ring to any extent, whether or not substituted in the
  tetramethylcyclopropyl ring to any extent, including:
                     A-836,339;
               Quinolinylindolecarboxylate: any compound structurally
  derived from quinolin-8-yl indole-3-carboxylate by substitution at
  the nitrogen atom of the indole ring with alkyl, haloalkyl, benzyl,
  halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl,
  hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
  (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
  2-(4-morpholinyl)alkyl, whether or not further substituted in the
  indole ring to any extent, whether or not substituted in the
  quinoline ring to any extent, including:
                     BB-22;
                     5-Fluoro PB-22; and
                     PB-22;
               Cyclohexylphenol: any compound [cyclohexylphenols]
  structurally derived from 2-(3-hydroxycyclohexyl)phenol by
  substitution at the 5-position of the phenolic ring by alkyl,
  haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy,
  cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl,
  (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or
  2-(4-morpholinyl)alkyl [2-(4-morpholinyl)ethyl], whether or not
  substituted in the cyclohexyl ring to any extent, including:
                     CP-55,940;
                     CP-47,497;
                     analogues of CP-47,497, including VII, V, VIII, I,
  II, III, IV, IX, X, XI, XII, XIII, XV, and XVI;
                     JWH-337;
                     JWH-344;
                     JWH-345; and
                     JWH-405; and
               cannabinol derivatives, except where contained in
  marihuana, including tetrahydro derivatives of cannabinol and
  3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
  such as:
                     Nabilone;
                     HU-210; and
                     HU-211[; and
                     [WIN-55,212-2].
         SECTION 3.  Section 481.106, Health and Safety Code, is
  amended to read as follows:
         Sec. 481.106.  CLASSIFICATION OF CONTROLLED SUBSTANCE
  ANALOGUE. For the purposes of the prosecution of an offense under
  this subchapter involving the manufacture, delivery, or possession
  of a controlled substance, Penalty Groups 1, 1-A, [and] 2, and 2-A
  include a controlled substance analogue that:
               (1)  has a chemical structure substantially similar to
  the chemical structure of a controlled substance listed in the
  applicable penalty group; or
               (2)  is specifically designed to produce an effect
  substantially similar to, or greater than, a controlled substance
  listed in the applicable penalty group.
         SECTION 4.  The change in law made by this Act applies only
  to an offense committed on or after the effective date of this Act.
  An offense committed before the effective date of this Act is
  governed by the law in effect on the date the offense was committed,
  and the former law is continued in effect for that purpose. For
  purposes of this section, an offense was committed before the
  effective date of this Act if any element of the offense occurred
  before that date.
         SECTION 5.  This Act takes effect January 1, 2014.
feedback